Weight Loss Treatment

A medical service, not a lifestyle product

Weight loss medication has, for understandable reasons, become a topic of high public interest. It has also been over-marketed and under-supervised in places, with online operators prescribing GLP-1 medications based on a quick form and minimal follow-up. We do not run that kind of service.

Our weight-loss programme is practitioner-led, assessment-based and review-based. It exists to support eligible adults whose medical picture justifies pharmacotherapy and who are ready to engage with sustained nutritional and activity change. If your BMI is in the healthy range and your goal is cosmetic weight loss, we will say honestly that this is not the right treatment for you — and we won't be offended if you'd rather we'd said yes.

Who is eligible

Eligibility for pharmacotherapy follows clinical guidance, typically:

• BMI ≥30, or
• BMI ≥27 with a weight-related condition (type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea).

It is not appropriate during pregnancy or planning pregnancy in the near term, in active eating disorders, in those with a history of medullary thyroid carcinoma or MEN2, in severe gastroparesis or pancreatitis history, and where realistic engagement with ongoing review is not possible.

How the programme works

After an initial 30–45 minute medical consultation — covering history, medications, goals, baseline bloodwork where indicated — we agree a plan. Where pharmacotherapy is appropriate, we prescribe a starting dose, schedule the dose escalation, demonstrate injection technique and provide written nutrition and lifestyle guidance.

Subsequent reviews track weight, side effects, tolerance and progress. Prescriptions are issued only with review — we will not refill indefinitely without seeing you. This is for your safety.

Honest expectations

Trial evidence for GLP-1 medications is impressive: clinically meaningful weight loss of 10–20% of total body weight over 12 months on average, alongside lifestyle intervention. Individual response varies widely. Side effects — nausea, reduced appetite, constipation — are common, particularly during dose escalation, and most settle. Serious side effects are rare but real, and we brief you fully.

Most importantly: what happens when you stop matters more than what happens while you're on the medication. Weight regain is common after discontinuation if lifestyle change hasn't been embedded. The medication makes change easier; it cannot sustain it for you. We talk about exit strategy from the first appointment, not at the end.

Why this isn't an online form

The cost of the programme reflects clinical assessment, supervision and review — not the medication alone. We think anyone offering GLP-1 medications without that supervision is taking shortcuts that aren't in their patients' interest. If we don't think it's right for you, we'll say so.